Vistagen Therapeutics, Inc. files current report with SEC

Vistagen Therapeutics, Inc. filed an 8-K covering SEC Item 2.05 and other material corporate events. Nelo verified the filing topics against the primary SEC document. This is a company disclosure filed with the SEC, not an SEC enforcement action.